Intelligent mos2 nanotheranostic for targeted and enzyme-/ph-/nir-responsive drug delivery to overcome cancer chemotherapy resistance guided by pet imaging
文献类型：期刊论文
| 作者 | Dong, Xinghua1,2; Yin, Wenyan1; Zhang, Xiao1; Zhu, Shuang1; He, Xiao1; Yu, Jie1; Xie, Jiani1; Guo, Zhao1; Yan, Liang1; Liu, Xiangfeng2 |
| 刊名 | Acs applied materials & interfaces
 |
| 出版日期 | 2018-01-31 |
| 卷号 | 10期号:4页码:4271-4284 |
| ISSN号 | 1944-8244 |
| 关键词 | Mos2 nanosheets Surface modification Targeting and p-gp inhibition Controlled therapy Theranostics |
| DOI | 10.1021/acsami.7b17506 |
| 通讯作者 | Yin, wenyan(yinwy@ihep.ac.cn) ; Gu, zhanjun() ; Zhao, yuliang(zhaoyuliang@ihep.ac.cn) |
| 英文摘要 | Chemotherapy resistance remains a major hurdle for cancer therapy in clinic because of the poor cellular uptake and insufficient intracellular release of dings. herein, an intelligent, multifunctional mos2 nanotheranostic (mos2-pei-ha) ingeniously decorated with biodegradable hyaluronic acid (ha) assisted by polyethyleneimine (pei) is reported to combat drug-resistant breast, cancer (mcf-7-adr) after loading with the chemotherapy drug doxorubicin (dox). ha can not only target cd44-overexpressing mcf-7-adr but also be degraded by hyaluronidase (haase) that is concentrated in the tumor microenvironment, thus accelerating dox release. furthermore, mos2 with strong near-infrared (nir) photothermal conversion ability can also promote the release of dox in the acidic tumor environment at a mild 808 nm laser irradiation, achieving a superior antitumor activity based on the programmed response to haase and nir laser actuator. most importantly, ha targeting combined with mild nir laser stimuli, rather than using hyperthermia, can potently downregulate the expression of drug resistance-related pllycoprotein (p-gp), resulting in greatly enhanced intracellular drug accumulation, thus achieving drug resistance reversal. after labeled with cu-64 by a simple chelation strategy, mos2 was employed for real-time positron emission tomography (pet) imaging of mcf-7-adr tumor in vivo. this multifunctional nanoplatform paves a new avenue for pet imaging-guided spatial-temporal-controlled accurate therapy of drug-resistant cancer. |
| WOS关键词 | METAL DICHALCOGENIDE NANOSHEETS ; UP-CONVERSION NANOPARTICLES ; PRODUCT P-GLYCOPROTEIN ; ONE-POT SYNTHESIS ; IN-VIVO ; POLYMERIC MICELLES ; PHOTOTHERMAL THERAPY ; TUMOR ; DOXORUBICIN ; GENE |
| WOS研究方向 | Science & Technology - Other Topics ; Materials Science |
| WOS类目 | Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary |
| 语种 | 英语 |
| 出版者 | AMER CHEMICAL SOC |
| WOS记录号 | WOS:000424728800125 |
| URI标识 | http://www.irgrid.ac.cn/handle/1471x/2178046 |
| 专题 | 高能物理研究所 |
| 通讯作者 | Yin, Wenyan; Gu, Zhanjun; Zhao, Yuliang |
| 作者单位 | 1.Chinese Acad Sci, Inst High Energy Phys, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China 2.Univ Chinese Acad Sci, Coll Mat Sci & Optoelect Technol, Beijing 100049, Peoples R China 3.Chinese Acad Sci, Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, Beijing 100190, Peoples R China 4.Shandong Univ Sci & Technol, Inst Nano Engn, Sch Mat Sci & Engn, Qingdao 266590, Peoples R China |
| 推荐引用方式 GB/T 7714 | Dong, Xinghua,Yin, Wenyan,Zhang, Xiao,et al. Intelligent mos2 nanotheranostic for targeted and enzyme-/ph-/nir-responsive drug delivery to overcome cancer chemotherapy resistance guided by pet imaging[J]. Acs applied materials & interfaces,2018,10(4):4271-4284. |
| APA | Dong, Xinghua.,Yin, Wenyan.,Zhang, Xiao.,Zhu, Shuang.,He, Xiao.,...&Zhao, Yuliang.(2018).Intelligent mos2 nanotheranostic for targeted and enzyme-/ph-/nir-responsive drug delivery to overcome cancer chemotherapy resistance guided by pet imaging.Acs applied materials & interfaces,10(4),4271-4284. |
| MLA | Dong, Xinghua,et al."Intelligent mos2 nanotheranostic for targeted and enzyme-/ph-/nir-responsive drug delivery to overcome cancer chemotherapy resistance guided by pet imaging".Acs applied materials & interfaces 10.4(2018):4271-4284. |
入库方式： iSwitch采集
来源：高能物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。